Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model (Q4687148): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Created a new Item
 
Normalize DOI.
 
(4 intermediate revisions by 4 users not shown)
Property / DOI
 
Property / DOI: 10.1093/imammb/dqv007 / rank
Normal rank
 
Property / Wikidata QID
 
Property / Wikidata QID: Q50928785 / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1093/imammb/dqv007 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2032892681 / rank
 
Normal rank
Property / DOI
 
Property / DOI: 10.1093/IMAMMB/DQV007 / rank
 
Normal rank
links / mardi / namelinks / mardi / name
 

Latest revision as of 15:04, 30 December 2024

scientific article; zbMATH DE number 6951505
Language Label Description Also known as
English
Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model
scientific article; zbMATH DE number 6951505

    Statements

    Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model (English)
    0 references
    0 references
    0 references
    11 October 2018
    0 references
    mathematical modelling
    0 references
    bladder cancer
    0 references
    BCG immunotherapy
    0 references
    BCG and IL-2 combined therapy
    0 references
    immune system cells dynamics
    0 references

    Identifiers